Endothelium-derived hyperpolarizing factor(s): Species and tissue heterogeneity

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 2, 1999, Pages 176-179

  Triggle, C R ^a   Dong, H ^a   Waldron, G J ^a   Cole, W C ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cytochrome P450; Endothelium; Endothelium derived relaxing factor; Epoxyeicosatrienoic acid; Hyperpolarizing factor; K+ channels; Nitric oxide; Prostacyclin; Vascular smooth muscle

Indexed keywords

BIOLOGICAL FACTOR; ENDOTHELIUM DEPENDENT HYPERPOLARIZATION FACTOR; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION FACTOR; NITRIC OXIDE; PROSTACYCLIN;

ANIMAL; ARTICLE; BRAIN ARTERY; CAROTID ARTERY; GUINEA PIG; MESENTERIC ARTERY; METABOLISM; RABBIT; SPECIES DIFFERENCE; TISSUE DISTRIBUTION;

ANIMALS; BIOLOGICAL FACTORS; CAROTID ARTERIES; CEREBRAL ARTERIES; EPOPROSTENOL; GUINEA PIGS; MESENTERIC ARTERIES; NITRIC OXIDE; RABBITS; SPECIES SPECIFICITY; TISSUE DISTRIBUTION;

EID: 0033069799     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03007.x     Document Type: Conference Paper

References (36)

1. Furchgot RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acelylcholine. Nature 1980; 288: 373-6.
2. Palmer RMJ, Ferrige AG, Moncada S, Nitric oxide release accounts for biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
3. Moncada S, Gryglewski RJ, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663-5.
4. Garland CJ, Plane F, Kemp BK, Cocks TM. Endothelium-dependent hyperpolarization: A role in the control of vascular tone. Trends Pharmacol. Sci. 1995; 16: 23-30.
5. Waldron GJ, Dong H, Cole WC, Triggle CR. Endothelium-dependent hyperpolarization of vascular smooth muscle: Role for a non-nitric oxide synthase product. Acta Pharmacol. Sin. 1996; 17: 3-7.
6. Mombouli J-V, Vanhoutte PM. Endothelium-derived hyperpolarizing factor(s): Updating the unknown. Trends Pharmacol. Sci. 1997; 18: 252-6.
7. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br. J. Pharmacol. 1988; 93: 515-24.
8. Bény J-L, Brunet PC. Neither nitric oxide nor nitroglycerin accounts for all the characteristics of endothelially mediated vasodilation of pig coronary arteries. Blood Vessels 1988; 25: 302-11.
9. Chen G, Yamamoto Y, Miwa K, Suzuki H. Hyperpolarization of arterial smooth muscle induced by endothelial humoral substances. Am. J. Physiol. 1991; 260: H1888-92.
10. Popp R, Bauersachs J, Hecker M, Fleming I, Busse R. A transferable, β-naphthoflavone-inducible, hyperpolarizing factor is synthesised by native and cultured porcine coronary endothclial cells. J. Physiol. 1996; 497: 609-709.
11. 450 pathway in rabbit carotid artery. Br J. Pharmacol. 1997; 120: 695-701.
12. Rubanyi CM, Vanhoutte PM. Nature of endothelium-derived relaxing factor: Are there two relaxing mediators? Circ. Res. 1987; 61: II-61-7.
13. Komori K, Vanhoutte PM. Endothelium-derived hyperpolarizing factor. Blood Vessels. 1990; 27: 238-45.
14. 450 enzyme activity. Circ. Res. 1996; 79: 827-33.
15. Heeker M, Bara AT, Bauersachs J, Russe R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P-450-derived arachidonic acid metabolite in mammals. J. Physiol. 1994; 481: 407-14.
16. Randall MD, Alexander SPH, Bennett T et al. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Commun. 1996, 229; 114-20.
17. Plane F, Holland M, Waldron GJ, Garland CJ, Boyle JP, Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. Br. J. Pharmacol. 1997; 121: 1509-11.
18. Corriu C, Feletou M, Canet E, Vanhoutte PM. Inhibitors of the cytochrome P450-mono-oxygenase and endothelium-dependent hyperpolarizations in the guinea-pig isolated carotid artery. Br. J. Pharmacol. 1997; 117; 607-10.
19. Fukao M, Hattori Y, Kanno M, Sakuma I, Kitabatake A. Evidence against a role of cytochrome P450-derived arachidonic aeid metabolites in endothelium-dependent hyperpolarization by acetylcholine in rat isolated mesemeric artery. Br. J. Pharmacol. 1997; 120: 439-46.
20. Yamakawa N, Ohhashi M, Waga S, Itoh T. Role of endothelium in regulation of smooth muscle membrane potenlial and lone in the middle cerebral anery. Br. J. Pharmacol. 1997; 121: 1315-22.
21. Dong II, Waldron GJ, Cole WC, Triggle CR. Roles of calcium-activated and voltage-gated delayed rectifier potassium channels in endothelium-dependent vasorelaxation of the rabbit middle cerebral artery. Br. J. Biochem. 1998; 123: 821-32.
22. e: A functional approach to separating EDHF-and EDNO-related mechanisms in the perfused rat mesenteric arterial bed. J. Cardiovasc. Pharmacol. 1993; 21: 423-9.
23. + channels in mediating heterogeneous microvascular responses to acetylcholine in different vascular beds. J. Pharmacol. Exp. Ther. 1997; 282: 1473-9.
24. Harder DR, Campbell WB, Roman RJ. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J. Vasc. Res. 1995; 32: 79-92.
25. Gebremedhin D, Ma Y-H, Falck JR, Roman R.I, VanRollins M, Harder D, Mechanism of action of cerebral epoxycicosatrienoic acids on cerebral arterial smooth muscle. Am. J. Physiol. 1992; 263: 11519-25.
26. 4 channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eutr. J. Pharmacol. 1993; 230: 215-21.
27. Campbell WB, Gebremedhnin D, Pratt DF, Harder DR. Identification of epoxycicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 1996; 78: 415-23.
28. 2+ entry in human and bovine endothelial cells. J. Physiol. 1995; 482: 259-74.
29. + channels by endothelium-derived relaxing factors. Clin. Exp. Pharmacol. Physiol. 1999; 26: 180-4.
30. Garland CJ, McPherson GA. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mescnterie artery. Br. J. Pharmarol. 1992; 105: 429-35.
31. ATP channels. Br. J. Pharmacol. 1997; 121: 271-9.
32. Erdhrügger W, Vischer P, Bauch HJ. Prostaglandin synthesis in endothelial-and vascular smooth muscle cells upon mechanical stimulation and stimulation with calcium ionophore A23187. Pharmacol. Rev. Commun. 1997; 9: 107-11.
33. Plane F, Garland CJ. Influence of contractile agonists on the mechanism of endothelium-dependent relaxation in rat isolated mesenteric artery. Br. J. Pharmacol. 1996; 119: 191-3.
34. 450 isoforms in rat liver. J. Pharmacol. Exp. Ther. 1997; 280: 1463-70.
35. Olmos L, Mombouli J-V, Illiano S, Vanhoutte PM. cGMP mediates the desensitization to hradykinin in isolated canine coronary arteries. Am. J. Physiol. 1995, 268: H865-70.
36. Kemp BK, Cocks TM. Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium-dependent relaxation to bradykinin in human small resistance-like coronary arteries. Br. J. Pharmacol. 1997; 120: 757-62.